CMC Asset Lead (Fully Remote)

Shennon Biotechnologies; United States; Remoto; USD 250.000 - 380.000; Tempo pieno

Descrizione del lavoro

Shennon Biotechnologies, based in San Francisco, seeks a senior CMC leader to own end-to-end CMC for a trispecific TCE program from discovery to IND. You will coordinate cross-functional teams, data packages, and regulatory strategy to move programs forward.

In this role, you will lead CDMO selection, monitor quality and budgets, and drive regulatory submissions. The ideal candidate has 12+ years in biologics CMC, with demonstrated IND experience and strong leadership in fast-paced biotech

Competenze

• PhD or BS/MS with 12+ years in biologics CMC.
• Experience taking a biologic to IND and managing CDMOs.

Mansioni

• Own CMC end-to-end for a trispecific TCE program from discovery to IND.
• Lead competitive CDMO selection, quality, budget, and regulatory submissions.

Conoscenze

CMC leadership

IND submissions

CDMO management

Biologics experience

Formazione

PhD or BS/MS in biologics/CMC

Descrizione del lavoro

• Developing precision immunotherapies for solid tumors with an integrated screening platform.
• Based in San Francisco with a collaborative, ownership-driven culture.

The Role:

• Own CMC end-to-end for a trispecific TCE program from discovery to IND.
• Lead competitive CDMO selection, quality, budget, and regulatory submissions.

Qualifications:

• PhD or BS/MS with 12+ years in biologics CMC.
• Experience taking a biologic to IND and managing CDMOs.

Shennon Biotechnologies is developing precision immunotherapies for solid tumors using an integrated platform that profiles millions of single-cell interactions in a single experiment. The company values collaboration, ownership and authenticity and is based in San Francisco.